{"id":15155,"date":"2019-01-17T16:27:03","date_gmt":"2019-01-17T15:27:03","guid":{"rendered":"https:\/\/news.embl.de\/?p=15155"},"modified":"2025-11-19T13:03:51","modified_gmt":"2025-11-19T12:03:51","slug":"miltenyi-biotec-joins-embls-corporate-partnership-programme","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/","title":{"rendered":"Miltenyi Biotec becomes new corporate partner"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">By Julian Samojlow<\/h3>\n\n\n\n<p>EMBL and Miltenyi Biotec, a global provider of products and services that advance biomedical research and cellular therapy from basic and translational research to clinical application, have teamed up in the&nbsp;<a href=\"http:\/\/embl.de\/aboutus\/support-embl\/corporate-partnership-programme\" target=\"_blank\" rel=\"noopener noreferrer\">EMBL Advanced Training Centre Corporate Partnership Programme<\/a> to advance research in the life sciences.<\/p>\n\n\n\n<p>\u201cMiltenyi Biotech has a long tradition of providing novel tools for state-of-the-art cell biology and accompanying this with a dedicated training scheme,\u201d says Malte Paulsen, Head of EMBL\u2019s Flow Cytometry Core Facility. \u201cMiltenyi becoming a partner in the Corporate Partnership Programme will strengthen EMBL\u2019s efforts to provide the best possible training on various topics in cell phenotyping, purification and targeted modification, from basic research to adaptive medicine. Knowledge is best transferred if real experience is backing it up.\u201d<\/p>\n\n\n\n<p>\u201cEMBL is the ideal partner for Miltenyi Biotec, as we share the same spirit of conducting groundbreaking research and giving the life science community access to the knowledge gained and the associated tools,\u201d says Oliver Burlon, vice-president of Miltenyi\u2019s MACS Services Business Unit. \u201cTraining is the key factor to leverage on these advancements and therefore this new partnership will bring new attractive offerings to researchers in Europe.\u201d<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">About the Corporate Partnership Programme<\/h4>\n\n\n\n<p>Founded in 2009, EMBL\u2019s Corporate Partnership Programme helps build mutually beneficial relationships between world-leading corporate partners and the academic community. In 2019, thanks to the generous support of&nbsp;Miltenyi Biotec and&nbsp;<a href=\"http:\/\/embl.de\/aboutus\/support-embl\/corporate-partnership-programme\/current-partners\" target=\"_blank\" rel=\"noopener noreferrer\">current members of the programme<\/a>, more than 200 talented young scientists will receive financial assistance, enabling them to contribute to and participate in courses and conferences at EMBL.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Joining forces to advance training in biomedical research and therapy<\/p>\n","protected":false},"author":16,"featured_media":15160,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17595,3],"tags":[297,172,71,25,13072,27],"embl_taxonomy":[19535,5802],"class_list":["post-15155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-connections","category-lab-matters","tag-biomedical","tag-corporate-partnership-programme","tag-industry","tag-partnerships","tag-support-embl","tag-training","embl_taxonomy-corporate-partnership-programme","embl_taxonomy-support-embl"],"acf":{"article_intro":"<p>Joining forces to advance training in biomedical research and therapy<\/p>\n","related_links":[{"link_description":"","link_url":""},{"link_description":"","link_url":""}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"field_target_display":"embl","source_article":false,"in_this_article":false,"press_contact":"None","vfwp-news_embl_taxonomy":[19535,5802],"field_article_language":{"value":"english","label":"English"},"article_translations":false,"languages":""},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";i:2;s:36:\"0d3270ca-455c-428a-86f4-c61b1de8c3e0\";}","parents":[],"name":["Corporate Partnership Programme"],"slug":"corporate-partnership-programme","description":"What &gt; Support EMBL &gt; Corporate Partnership Programme"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"bc1eaadd-1f50-4140-8e9b-e58fc33a39fc\";i:2;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";}","parents":[],"name":["Support EMBL"],"slug":"support-embl","description":"What &gt; About EMBL &gt; Support EMBL"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Miltenyi Biotec becomes new corporate partner | EMBL<\/title>\n<meta name=\"description\" content=\"EMBL and Miltenyi Biotec join forces as part of EMBL&#039;s Corporate Partnership Programme, aiming to advance training in biomedical research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Miltenyi Biotec becomes new corporate partner | EMBL\" \/>\n<meta property=\"og:description\" content=\"EMBL and Miltenyi Biotec join forces as part of EMBL&#039;s Corporate Partnership Programme, aiming to advance training in biomedical research.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-17T15:27:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-19T12:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"426\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Guest author(s)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guest author(s)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\"},\"author\":{\"name\":\"Guest author(s)\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\"},\"headline\":\"Miltenyi Biotec becomes new corporate partner\",\"datePublished\":\"2019-01-17T15:27:03+00:00\",\"dateModified\":\"2025-11-19T12:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\"},\"wordCount\":267,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg\",\"keywords\":[\"biomedical\",\"corporate partnership programme\",\"industry\",\"partnerships\",\"support embl\",\"training\"],\"articleSection\":[\"Connections\",\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\",\"name\":\"Miltenyi Biotec becomes new corporate partner | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg\",\"datePublished\":\"2019-01-17T15:27:03+00:00\",\"dateModified\":\"2025-11-19T12:03:51+00:00\",\"description\":\"EMBL and Miltenyi Biotec join forces as part of EMBL's Corporate Partnership Programme, aiming to advance training in biomedical research.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg\",\"width\":620,\"height\":426,\"caption\":\"Miltenyi Biotec logo\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\",\"name\":\"Guest author(s)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"caption\":\"Guest author(s)\"},\"description\":\"Guest author(s)\",\"url\":\"https:\/\/www.embl.org\/news\/author\/guest-author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Miltenyi Biotec becomes new corporate partner | EMBL","description":"EMBL and Miltenyi Biotec join forces as part of EMBL's Corporate Partnership Programme, aiming to advance training in biomedical research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/","og_locale":"en_US","og_type":"article","og_title":"Miltenyi Biotec becomes new corporate partner | EMBL","og_description":"EMBL and Miltenyi Biotec join forces as part of EMBL's Corporate Partnership Programme, aiming to advance training in biomedical research.","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2019-01-17T15:27:03+00:00","article_modified_time":"2025-11-19T12:03:51+00:00","og_image":[{"width":620,"height":426,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","type":"image\/jpeg"}],"author":"Guest author(s)","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Guest author(s)","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/"},"author":{"name":"Guest author(s)","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b"},"headline":"Miltenyi Biotec becomes new corporate partner","datePublished":"2019-01-17T15:27:03+00:00","dateModified":"2025-11-19T12:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/"},"wordCount":267,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","keywords":["biomedical","corporate partnership programme","industry","partnerships","support embl","training"],"articleSection":["Connections","Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/","name":"Miltenyi Biotec becomes new corporate partner | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","datePublished":"2019-01-17T15:27:03+00:00","dateModified":"2025-11-19T12:03:51+00:00","description":"EMBL and Miltenyi Biotec join forces as part of EMBL's Corporate Partnership Programme, aiming to advance training in biomedical research.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/miltenyi-biotec-joins-embls-corporate-partnership-programme\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","width":620,"height":426,"caption":"Miltenyi Biotec logo"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b","name":"Guest author(s)","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","caption":"Guest author(s)"},"description":"Guest author(s)","url":"https:\/\/www.embl.org\/news\/author\/guest-author\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/01\/MB_Logo_violet_RGB_Schutzraum_for-web.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/15155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=15155"}],"version-history":[{"count":8,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/15155\/revisions"}],"predecessor-version":[{"id":77325,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/15155\/revisions\/77325"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/15160"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=15155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=15155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=15155"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=15155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}